物质信息
ID:335988
名称和标识
IUPAC标准名
tetrabutylazanium fluoride
别名
TBAF 溶液TBAF solution四丁基氟化铵 溶液Tetrabutylammonium fluoride solution
IUPAC传统名
tetrabutylammonium fluoride
化合物性质
理化性质
闪点
1.4 °F
-17 °C
密度
0.903 g/mL at 25 °C
安全信息
危险公开号
11-19-34-37
保存温度
2-8°C
GHS危险声明
H225-H314-H335
GHS警示性声明
P210-P261-P280-P305+P351+P338-P310
德国WGK号
3
联合国危险货物包装类别(PG)
2
GHS警示词
Danger
欧盟补充危害声明
May form explosive peroxides.
欧盟危险性物质标志
易燃性 (F)
腐蚀性 (C)GHS危险品标识
急性毒性（口服，皮肤接触，吸入），类别4
皮肤刺激，类别2
眼刺激，类别2
皮肤过敏，类别1
特定目标器官毒性 -一次接触，类别3
易燃气体类别1
易燃气溶胶，第1,2类
易燃液体，类别1,2,3
自反应物质和混合物，类型B，C，D，E，F
自燃液体类别1
自燃固体类别1
自我放热物质和混合物，类别1,2
与水接触的物质和混合物，放出易燃气体类别1,2,3
有机过氧化物，类别B，C，D，E，F
腐蚀金属，类别1
腐蚀皮肤，类别1A，1B，1C
严重眼损伤，类别1
联合国危险货物编号
2924
MSDS下载
RID/ADR
UN 2924 3/PG 2
安全公开号
16-26-36/37/39-45
联合国危险货物等级
3
产品相关信息
杂质
~5 wt. % water
浓度
1.0 M in THF
线性分子式
[CH3(CH2)3]4NF
描述信息
Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
包装
1 L in Sure/Seal™
5 mL in glass bottle
2, 2.5 L in glass bottle
50, 100, 500 mL in Sure/Seal™
Application
Reactant for preparation of:
• Triple monoamine reuptake inhibitors as a new generation of antidepressants1
• Alcohols via hydrolysis of alkyl silyl ethers neutral pH in mixed organic-aqueous buffered solutions2
• Oligoribonucleotides with phosphonate-modified linkages3
• Aryl alkyl alcohols via Nozaki-Hiyama allylation catalyzed by chiral bipyridyldiol ligands and chromium trichloride4
• Conjugated dienoic acid esters using Suzuki coupling reactions5
• Macrocyclic o-aminobenzamide Hsp90 inhibitorwith antitumor activity6
• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors7
• Anti-diabetic polyacetylenic glucosides8
Live Chat and Frequently Asked Questions are available for this Product.
包装
1 L in Sure/Seal™
5 mL in glass bottle
2, 2.5 L in glass bottle
50, 100, 500 mL in Sure/Seal™
Application
Reactant for preparation of:
• Triple monoamine reuptake inhibitors as a new generation of antidepressants1
• Alcohols via hydrolysis of alkyl silyl ethers neutral pH in mixed organic-aqueous buffered solutions2
• Oligoribonucleotides with phosphonate-modified linkages3
• Aryl alkyl alcohols via Nozaki-Hiyama allylation catalyzed by chiral bipyridyldiol ligands and chromium trichloride4
• Conjugated dienoic acid esters using Suzuki coupling reactions5
• Macrocyclic o-aminobenzamide Hsp90 inhibitorwith antitumor activity6
• Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors7
• Anti-diabetic polyacetylenic glucosides8
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据